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Introduction: Cancer stem cells (CsCs) have emerged to attractive cellular targets for the therapy 
of many solid tumors, including hepatocellular cancers. We have recently reported that activation of 
nf-kB signaling is consistently observed in human liver CsCs. Based on these data, we hypothesized 
that nf-kB may be a specific therapeutic target against CsCs. 
Methods: Inhibition of nf-kB signaling was performed using (i) curcumin, an effective Ikk inhibitor, 
(ii) sirnA against p65 and (iii) the specific inhibitory peptide sn50. Anti-proliferative and pro-
apoptotic capacity was evaluated in different liver cancer cell lines. the effect on CsC was assessed 
by the side Population (sP) approach, and expression levels of selected targets determined by 
rt-qPCr, gene expression microarray, eMsA, and Western blotting.
results: specific inhibition of nf-kB signaling by sn50 and sirnA caused a general suppression 
of cell growth accompanied by a drastic reduction in CsC properties. Curcumin treatment caused 
anti-proliferative and pro-apoptotic responses directly related to the extent of nf-kB inhibition. In 
curcumin-sensitive cell lines, the treatment selectively depleted CsCs and led to down-regulation of 
the CsC markers CD133, epCAM, nAnoG and c-kit. Conversely, curcumin-resistant cells exhibited a 
paradoxical response. Mechanistically, CsC-depleting activity was exerted by nf-kB mediated hDAC 
inhibition leading to down-regulation of c-MyC and other key oncogenic targets. Co-administration of 
a class I and II hDAC inhibitor sensitized the curcumin-resistant cells to curcumin treatment. further, 
integration of a predictive signature with our hCC database indicated that hCC patients with poor 
prognosis and progenitor cell features are most likely to benefit from nf-kB inhibition. 
Conclusion: these data demonstrate that nf-kB inhibition by curcumin can specifically target 
CsC populations. future investigations will determine the potential of combined inhibition of nf-kB 
signaling and hDAC for CsC-directed hCC therapy.
Disclosure of Interest: none Declared
P-021 The MuLTIKInASe InhIBITOr K252A InDuCeS MeSenChyMAL-
ePITheLIAL TrAnSITIOn In A MOuSe xenOGrAfT MODeL Of 
hePATOCeLLuLAr CArCInOMA
M. Abe 1,*, h. koga 1, t. yoshida 1, h. Masuda 1, M. sakata 1, y. Ikezono 1, t. nakamura 1, e. taniguchi 1, 
t. kawaguchi 1, h. yano 2, t. torimura 1
1Division of Gastroenterology, Department of Medicine, 2Department of Pathology, kurume university, 
kurume, japan
Introduction: there are several ongoing clinical trials of molecular-targeted therapy for 
hepatocellular carcinoma (hCC), but no clearly effective therapy has yet emerged. under such 
conditions, we have been focusing on potentially powerful anticancer effects of the novel multikinase 
inhibitor k252a, since it targets unique kinases, including PkC, CaMk II, c-Met, trkB, MLCk, and 
phosphorylase kinase. Indeed, the former five targets are expressed in hCC tissues and involved 
in cellular proliferation, invasion, and metastasis (yoshiji et al., Cancer res 1999, etc.). the broad 
spectrum of the targets may block escape pathways in hCC cells, that are resistant to conventional 
anticancer drugs and even sorafenib. the AIM of this study was to assess whether k252a altered 
malignant phenotypes such as epithelial-mesenchymal transition (eMt) both in vitro and in vivo.
Methods: the human hCC cell lines hAk-1A, hAk-1B (yano et al., hepatology 1993), kyn-2 (yano 
et al., Pathol Int 1988), and huh7 were used in this study. Protein expression and localization was 
analyzed by Western blot and immunocytochemistry, respectively. Cellular mrnA level was evaluated 
by real-time PCr using taqMan probes. hAk-1B-based xenograft model in nude mice was used to 
evaluate in-vivo efficacy of k252a.
results: k252a induced both polygonal transformation in cell shape and increase in cell size in 
several hCC cell lines having endogenous mesenchymal features. In Western blot analysis and 
immunocytochemistry, the expression levels of e2A, an eMt-regulating transcriptional factor, were 
universally decreased in the cells treated with k252a, in concert with increased expression levels 
of e-cadherin in some cell lines. In real-time PCr analyses, the decrease in e2A mrnA levels 
and the increase in e-cadherin mrnA levels were ubiquitously found. of note, xenografted tumor 
tissues obtained from mice treated with k252a exhibited significant increase in e-cadherin protein 
expression, in comparison with those from control mice.
Conclusion: our findings suggest that k252a has antitumor effects on hCC through, at least in 
part, reversing eMt. this kind of multikinase inhibitor may help us establish the proof-of-concept for 
closing escape routes in drug-resistant hCC cells.
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Introduction: hepatocellular carcinoma (hCC) is the second/third most common fatal cancer in 
hong kong and southeast Asia associated with frequent tumor recurrence and metastasis. Apart 
from surgical intervention, tumor control at cellular and molecular levels can possibly improve clinical 
outcome. hCC is characteristically one of the most rapidly proliferating tumors which often outpace 
functional blood supply, leading to a regional oxygen deprivation. therefore, molecular changes 
induced by hypoxia are attractive therapeutic targets. overexpression of PIM1, a serine/threonine 
kinase, has been identified in recent years in solid cancers such as prostate cancer, gastric cancer, 
and pancreatic cancer. In the latter, PIM1 was upregulated by hypoxia. In this study, we aim at 
investigating the expression, functional role, and regulatory mechanism of PIM1 in hCC, which have 
not been reported to date.
Methods: expression of PIM1 in clinical hCC samples and hCC cell lines was assessed by 
immunohistochemical method and Western blotting, respectively. functional significance of PIM1 in 
hCC was examined by cell proliferation and Matrigel invasion assays.
results: Immunohistochemical analysis in 20 paired primary and extra-hepatic metastatic hCC 
tissues showed that PIM1 was overexpressed in 10 (50%) primary hCC tissues. In the corresponding 
extra-hepatic metastatic hCC tissues, 17 cases (85%) expressed PIM1. these findings suggest 
that PIM1 overexpression may play a role in promoting hCC metastasis. By Western blotting, PIM1 
expression was markedly upregulated in multiple hCC cell lines upon hypoxic condition (1% o2) 
versus normoxia (20% o2). By in vitro experiments with stable PIM1-knockdown clones, we observed 
a decrease in cell invasion as compared to non-target controls. this inhibitory effect became more 
pronounced under hypoxic condition. In addition, knockdown of PIM1 decreased cell proliferation 
rate in vitro. to explore the regulatory mechanism of PIM1 upregulation under hypoxia in hCC, we 
performed a time-point experiment, in which upregulation of PIM1 protein expression occurred at 
~30 minutes upon hypoxic treatment and preceded that of hIf-1α, suggesting that the upregulation 
is hIf-1α independent and possibly related to post-translational events. By treating hCC cells with 
MG132 in normoxia, PIM1 protein level was stabilized and increased. the result suggested that 
hypoxia directly induced PIM1 by preventing the proteosomal degradation of PIM1 in hCC.
Conclusion: PIM1 is upregulated by hypoxia in hCC in an hIf-1α independent manner and 
promotes tumor growth and metastasis. 
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Introduction: Primary liver cancer is the fifth most common cancer worldwide and the third most 
common cause of cancer mortality. hepatocellular carcinoma (hCC) accounts for more than 80% of 
primary liver cancers. the expression of Glycine n-methyltransferase (GnMt), a tumor suppressor 
gene for hCC, is down-regulated in more than 75% hCC patients. Previously, we reported that very 
high rate of Gnmt gene knockout (Gnmt-/-) mice developed hCC at about fourteen to eighteen 
months. the objective of this study is to establish and characterize hCC cell line from this mouse 
model.
Methods: Liver tumor from Gnmt-/- mice were cut into small pieces and digested by collagenase 
and trypsin. the resultant cells were seeded in culture dishes and subcultured for more than 60 
passages. Allograft tumors were established both subcutaneously and intrahepatically and were 
harvested for histological examination. the expression profile of genes related to eMt and cancer 
stem cell like properties were determined by q-PCr and western blot. side population assay and 
sphere forming assay were used to evaluate the cancer stem cell like properties of our cell lines.
results: We established three liver cancer cell lines, ymac-1, ymac-2, and ymac-4. to investigate 
the tumorigenicity of these cell lines in vivo, they were injected subcutaneously into noD/sCID 
mice. ymac-1 and ymac-4 can form tumor in vivo, but ymac-2 cannot. the histopathological study 
of tumors from ymac-1 and ymac-4 revealed that ymac-1 has spindle shape like sarcomatoid 
hepatocyte carcinoma (shC) morphology and ymac-4 has bile duct like Cholangiocarcinoma 
